Daniel E. Kolker

Array ( [id] => 4599722 [patent_doc_number] => 07977317 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => 'Compositions and methods for modulating blood-brain barrier transport' [patent_app_type] => utility [patent_app_number] => 12/683651 [patent_app_country] => US [patent_app_date] => 2010-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 47 [patent_no_of_words] => 32660 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977317.pdf [firstpage_image] =>[orig_patent_app_number] => 12683651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6485502 [patent_doc_number] => 20100092990 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-15 [patent_title] => 'NUCLEIC ACIDS ENCODING SODIUM CHANNEL SCN1A ALPHA SUBUNIT PROTEINS AND MUTATIONS ASSOCIATED WITH EPILEPSY' [patent_app_type] => utility [patent_app_number] => 12/637219 [patent_app_country] => US [patent_app_date] => 2009-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 18175 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20100092990.pdf [firstpage_image] =>[orig_patent_app_number] => 12637219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6148732 [patent_doc_number] => 20110020327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'Purification of proteins' [patent_app_type] => utility [patent_app_number] => 12/592744 [patent_app_country] => US [patent_app_date] => 2009-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12610 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20110020327.pdf [firstpage_image] =>[orig_patent_app_number] => 12592744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6586179 [patent_doc_number] => 20100047911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'COMPOSITIONS AND METHODS FOR ISOLATION, PROPAGATION, AND DIFFERENTIATION OF HUMAN STEM CELLS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/610071 [patent_app_country] => US [patent_app_date] => 2009-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15601 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20100047911.pdf [firstpage_image] =>[orig_patent_app_number] => 12610071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6223289 [patent_doc_number] => 20100056604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-04 [patent_title] => 'METHODS FOR STIMULATING NERVOUS SYSTEM REGENERATION AND REPAIR BY INHIBITING PHOSPHODIESTERASE TYPE IV' [patent_app_type] => utility [patent_app_number] => 12/604743 [patent_app_country] => US [patent_app_date] => 2009-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 16869 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0056/20100056604.pdf [firstpage_image] =>[orig_patent_app_number] => 12604743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515153 [patent_doc_number] => 08039224 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Gene specifically expressed in postmitotic dopaminergic neuron precursor cells' [patent_app_type] => utility [patent_app_number] => 12/575946 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17987 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039224.pdf [firstpage_image] =>[orig_patent_app_number] => 12575946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6608522 [patent_doc_number] => 20100099184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-22 [patent_title] => 'POLYNUCLEOTIDES ENCODING CLASS II CYTOKINE RECEPTOR-7' [patent_app_type] => utility [patent_app_number] => 12/571563 [patent_app_country] => US [patent_app_date] => 2009-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13162 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20100099184.pdf [firstpage_image] =>[orig_patent_app_number] => 12571563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6359031 [patent_doc_number] => 20100087375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'Modulation of synaptogenesis' [patent_app_type] => utility [patent_app_number] => 12/586104 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 17287 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20100087375.pdf [firstpage_image] =>[orig_patent_app_number] => 12586104 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6386592 [patent_doc_number] => 20100077498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-25 [patent_title] => 'COMPOSITIONS AND METHODS FOR BLOOD-BRAIN BARRIER DELIVERY IN THE MOUSE' [patent_app_type] => utility [patent_app_number] => 12/558348 [patent_app_country] => US [patent_app_date] => 2009-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 26431 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20100077498.pdf [firstpage_image] =>[orig_patent_app_number] => 12558348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6587826 [patent_doc_number] => 20100061934 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Methods for diagnosis or treatment of amyloidosis by targeting hyper-sulfated proteoglycans present in amyloid' [patent_app_type] => utility [patent_app_number] => 12/584522 [patent_app_country] => US [patent_app_date] => 2009-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3204 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20100061934.pdf [firstpage_image] =>[orig_patent_app_number] => 12584522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4594970 [patent_doc_number] => 07981417 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-19 [patent_title] => 'Blood-brain barrier targeting anti-bodies' [patent_app_type] => utility [patent_app_number] => 12/540897 [patent_app_country] => US [patent_app_date] => 2009-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 21957 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/981/07981417.pdf [firstpage_image] =>[orig_patent_app_number] => 12540897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6252126 [patent_doc_number] => 20100028370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'MEGALIN-BASED DELIVERY OF THERAPEUTIC COMPOUNDS TO THE BRAIN AND OTHER TISSUES' [patent_app_type] => utility [patent_app_number] => 12/508956 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 41275 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20100028370.pdf [firstpage_image] =>[orig_patent_app_number] => 12508956 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551818 [patent_doc_number] => 20090285804 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'Anti-ADDLs antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/486313 [patent_app_country] => US [patent_app_date] => 2009-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 28219 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285804.pdf [firstpage_image] =>[orig_patent_app_number] => 12486313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6431044 [patent_doc_number] => 20100143365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'METHODS AND MATERIALS RELATED TO ANTI-AMYLOID ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/479446 [patent_app_country] => US [patent_app_date] => 2009-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 8980 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143365.pdf [firstpage_image] =>[orig_patent_app_number] => 12479446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8028459 [patent_doc_number] => 08143311 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-03-27 [patent_title] => 'Methods of treating fragile X syndrome and autism' [patent_app_type] => utility [patent_app_number] => 12/454202 [patent_app_country] => US [patent_app_date] => 2009-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 19005 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/143/08143311.pdf [firstpage_image] =>[orig_patent_app_number] => 12454202 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373713 [patent_doc_number] => 20090311274 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 238P1B2 USEFUL IN TREATMENT AND DETECTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/429012 [patent_app_country] => US [patent_app_date] => 2009-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 172571 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311274.pdf [firstpage_image] =>[orig_patent_app_number] => 12429012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5480657 [patent_doc_number] => 20090203614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'USE OF AGENTS THAT PREVENT THE GENERATION OF AMYLOID-LIKE PROTEINS AND/OR DRUSEN, AND/OR USE OF AGENTS THAT PROMOTE SEQUESTRATION AND/OR DEGRADATION OF, AND/OR PREVENT THE NEUROTOXIC EFFECTS OF SUCH PROTEINS IN THE TREATMENT OF MACULAR DEGENERATION' [patent_app_type] => utility [patent_app_number] => 12/425774 [patent_app_country] => US [patent_app_date] => 2009-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4681 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0203/20090203614.pdf [firstpage_image] =>[orig_patent_app_number] => 12425774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6538466 [patent_doc_number] => 20100221748 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'AMPK modulation as a method of regulating stem cell and cancer stem cell proliferation, self-renewal and differentiation' [patent_app_type] => utility [patent_app_number] => 12/384446 [patent_app_country] => US [patent_app_date] => 2009-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 59 [patent_no_of_words] => 19429 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20100221748.pdf [firstpage_image] =>[orig_patent_app_number] => 12384446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515813 [patent_doc_number] => 20090216120 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Method for Measuring Hydration of Soft Tissue' [patent_app_type] => utility [patent_app_number] => 12/371357 [patent_app_country] => US [patent_app_date] => 2009-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3917 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20090216120.pdf [firstpage_image] =>[orig_patent_app_number] => 12371357 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515828 [patent_doc_number] => 20090216135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Method, assembly, catheter, and processing device for obtaining an indication of cardiac output' [patent_app_type] => utility [patent_app_number] => 12/322808 [patent_app_country] => US [patent_app_date] => 2009-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4001 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20090216135.pdf [firstpage_image] =>[orig_patent_app_number] => 12322808 [rel_patent_id] =>[rel_patent_doc_number] =>)